Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MCK

Washington, Drug Distributors Reach $518M Settlement For Opioid Claims

Washington has reached a $518 million settlement with drug distributors McKesson Corporation (NYSE:MCK), AmerisourceBergen Corp (NYSE:ABC), and Cardinal Health Inc (NYSE:CAH) to resolve opioid-related claims. Washington opted out of a $26 billion nationwide opioid settlement involving the three drug distributors and Johnson & Johnson (NYSE:JNJ). Reuters writes that it would…

4 Medical Distributor Stocks That Deserve a Place in Your Portfolio

4 Medical Distributor Stocks That Deserve a Place in Your Portfolio

The rising demand for drugs and other medical products over the past few years has significantly increased the importance of healthcare distributors. Furthermore, the adoption of advanced and emerging technologies in the healthcare supply chain should help the medical distribution market grow robustly. So, we think the shares of fundamentally…

5 Non-Cyclical Stocks to Buy Now if You're Worried About a Recession

5 Non-Cyclical Stocks to Buy Now if You're Worried About a Recession

As surging inflation and energy prices foster recessionary fears, it could be wise to bet on non-cyclical stocks because they tend to outperform the broader market when economic growth slows. Given the inelastic demand for their companies’ products, we think the shares of United Parcel Service (UPS), British American Tobacco…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

3 Top-Rated Stocks for Value Investors to Consider

The recent stock market correction has created a few attractive opportunities for investors because many stocks are now trading at reasonable valuations. Thus, it could be wise now to invest in fundamentally solid stocks Bristol-Myers (BMY), McKesson (MCK), and AGCO (AGCO). These names are currently trading at discounts compared to…

5 No-Brainer Dividend Stocks to Buy for a Recession

Multi-decade high inflation and rising energy prices have stoked recession fears. Therefore, we think investors looking to sidestep a potentially intensifying stock-market downtrend could bet on quality dividend stocks UnitedHealth (UNH), General Dynamics (GD), McKesson (MCK), Waste Connections (WCN), and AmerisourceBergen (ABC). Let’s discuss.

Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits

Distributors McKesson Corporation (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH

5 Best Healthcare Stocks to Buy as a Hedge Against Inflation

The healthcare sector has historically provided a better hedge against inflation than gold because of the inelastic demand for its products and services. Rising healthcare needs of an aging population, integration of advanced technologies, and breakthroughs in clinical trials brighten the sector’s prospects. Therefore, fundamentally-sound and undervalued healthcare stocks Sanofi…

inkl

Read news from The Economist, FT, and more,
with one subscription

Stabilize Your Portfolio with These 5 High-Quality Stocks

Stabilize Your Portfolio with These 5 High-Quality Stocks

The stock indices are down, heading for a second straight losing week on investor concerns about geopolitical tensions and the Fed’s actions. And the market is expected to remain volatile in the near term. Hence, we think high-quality stocks Merck & Co. (MRK), Archer-Daniels-Midland (ADM), Baxter (BAX), McKesson (MCK), and…

Buy These 3 Stable Dividend Stocks to Protect Your Portfolio from Increased Volatility

Buy These 3 Stable Dividend Stocks to Protect Your Portfolio from Increased Volatility

Soaring inflation, heightened geopolitical tensions, and the Fed’s decision to raise interest rates multiple times this year have fostered severe market volatility of late. So, we think investors looking to protect their portfolios from rising volatility should consider adding quality dividend-paying stocks McKesson (MCK), AmerisourceBergen (ABC), and ORIX (IX) to…

Analyst Ratings For McKesson

Analyst Ratings For McKesson

McKesson (NYSE:MCK) has observed the following analyst ratings within the last quarter:

McKesson's Return on Invested Capital Insights

McKesson's Return on Invested Capital Insights

Pulled from Benzinga Pro data, McKesson (NYSE:MCK) showed a loss in earnings since Q2, totaling $39.00 million. Sales, on the other hand, increased by 3.06% to $68.61 billion during Q3.

McKesson Q3 Earnings Beat Street View, Raises FY22 Outlook Boosted By COVID-19 Vaccine Demand

McKesson Q3 Earnings Beat Street View, Raises FY22 Outlook Boosted By COVID-19 Vaccine Demand

McKesson Corp (NYSE: MCK) reported

Recap: McKesson Q3 Earnings

Recap: McKesson Q3 Earnings

McKesson (NYSE:MCK) reported its Q3 earnings results on Wednesday, February 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

McKesson Earnings Preview

McKesson Earnings Preview

McKesson (NYSE:MCK) is set to give its latest quarterly earnings report on Wednesday, 2022-02-02. Here's what investors need to know before the announcement. Analysts estimate that McKesson will likely report an Earnings Per Share (EPS) of $5.42.

Get all your
news in one place.

100’s of premium titles.
One news app.

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

BristolMyers Squibb Company

Cardinal Health

McKesson Corporation

Cardinal Health Inc

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

332,379 stories

Washington D.C.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play